Cited by 132Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Post-Pubertal Disruption of Medial Prefrontal Cortical Dopamine–Glutamate Interactions in a Developmental Animal Model of Schizophrenia

Open access
Tseng, Kuei-Yuan, Lewis, Barbara L., Lipska, Barbara K., O’Donnell, Patricio·2007·Biological Psychiatry

Abstract

Background A neonatal ventral hippocampal lesion (NVHL) induces behavioral and physiological anomalies mimicking pathophysiological changes of schizophrenia. Because prefrontal cortical (PFC) pyramidal neurons recorded from adult NVHL rats exhibit abnormal responses to activation of the mesocortical dopaminergic (DA) system, we explored whether these changes are due to an altered DA modulation of pyramidal neurons.Methods Whole-cell recordings were used to examine the effects of DA and glutamate agonists on cell excitability in brain slices obtained from pre- (postnatal day [PD] 28-35) and post-pubertal (PD > 61) sham and NVHL animals.Results N-methyl d-aspartate (NMDA), alpha-amino-3-hydroxy-5-methylisoxazole propionate (AMPA), and the D(1) agonist SKF38393 increased excitability of deep layer pyramidal neurons in a concentration-dependent manner. The opposite effect was observed with the D(2) agonist quinpirole. The effects of NMDA (but not AMPA) and SKF38393 on cell excitability were significantly higher in slices from NVHL animals, whereas quinpirole decrease of cell excitability was reduced. These differences were not observed in slices from pre-pubertal rats, suggesting that PFC DA and glutamatergic systems become altered after puberty in NVHL rats.Conclusions A disruption of PFC dopamine-glutamate interactions might emerge after puberty in brains with an early postnatal deficit in hippocampal inputs, and this disruption could contribute to the manifestation of schizophrenia-like symptoms.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2006.10.012

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recordings in brain slices revealed increased excitability of pyramidal neurons and a deficient activation of fast-spiking GABA interneurons by D2 agonists in the PFC of NVHL rats.

    “Recordings in brain slices revealed increased excitability of pyramidal neurons 52 and a deficient activation of fast-spiking GABA interneurons by D 2 agonists 53 in the PFC of NVHL rats.”

The citation lists haven’t been fetched yet

References 42 · Cited by 132

Authors
Tseng, K.-Y., Lewis, B. L., Lipska, B. K., & O’Donnell, P.
Affiliations
  • Rosalind Franklin University of Medicine and Science (US)
  • Albany Medical College (US)
  • National Institute of Mental Health (US)
  • University of Maryland, Baltimore (US)
Corresponding author
O’Donnell, Patricio
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2007-10
Volume
62
Issue
7
Pages
730-738
ISSN
0006-3223 (ISSN-L)
OpenAlex
W1966465143
Cited by
132
References
42
Citations by year
2025: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 8 · 2014: 6 · 2013: 11 · 2012: 12
FWCI
10.25
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Mental Health (MH57683, R56MH057683, R01MH057683)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
schizophrenia, dopamine-glutamate interaction, medial prefrontal cortex, pyramidal neurons, excitability, NMDA receptor, AMPA receptors, dopamine D1 receptor, dopamine D2 receptor, quinpirole, SKF 38393, ventral hippocampus, animal models of schizophrenia
MeSH terms
Animals, Animals, Newborn, Disease Models, Animal, Dopamine, Electrophysiology, Female, Hippocampus, Neurons, Pregnancy, Schizophrenia, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, N-Methylaspartate, Rats, Sprague-Dawley, Prefrontal Cortex, Receptors, Dopamine D1, Receptors, Dopamine D2, Pyramidal Cells, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid, Patch-Clamp Techniques, Dopamine Agonists, Excitatory Amino Acid Agonists, Glutamic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review